Who owns TENAX THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of TENX from SEC Form 13F filings across 110 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 110 institutions disclosed 30.3M shares of TENAX THERAPEUTICS, INC. worth $441.1M — about 59.6% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
110
13F holders
$441.1M
value, 2026 filers
59.6%
of shares outstanding (30.3M sh)
44
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of TENX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | FMR LLC | 3.9M | $57.4M | 0.0% | 7.8% | +1122.1% |
| 2 | Vivo Capital, LLC | 2.5M | $36.4M | 3.3% | 4.9% | +1100.0% |
| 3 | BlackRock, Inc. | 1.7M | $25.1M | 0.0% | 3.4% | +10078.4% |
| 4 | PERCEPTIVE ADVISORS LLC | 1.7M | $24.7M | 0.4% | 3.3% | +17.4% |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 1.1M | $16.7M | 0.0% | 2.3% | +335.5% |
| 6 | MILLENNIUM MANAGEMENT LLC | 876,230 | $12.7M | 0.0% | 1.7% | +64.1% |
| 7 | Ikarian Capital, LLC | 787,600 | $11.5M | 1.2% | 1.5% | -22.6% |
| 8 | Candriam S.C.A.NEW | 749,588 | $10.9M | 0.0% | 1.5% | new |
| 9 | CITADEL ADVISORS LLC | 728,561 | $10.6M | 0.0% | 1.4% | +377.7% |
| 10 | RTW INVESTMENTS, LP | 696,570 | $10.1M | 0.1% | 1.4% | +88.1% |
| 11 | Stonepine Capital Management, LLC | 660,000 | $9.6M | 5.4% | 1.3% | -32.3% |
| 12 | GEODE CAPITAL MANAGEMENT, LLC | 639,537 | $9.3M | 0.0% | 1.3% | +824.7% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 607,660 | $8.8M | 0.0% | 1.2% | -79.4% |
| 14 | MARSHALL WACE, LLP | 585,578 | $8.5M | 0.0% | 1.2% | +66.1% |
| 15 | BRAIDWELL LPNEW | 584,412 | $8.5M | 0.3% | 1.1% | new |
| 16 | Point72 Asset Management, L.P. | 556,761 | $8.1M | 0.0% | 1.1% | +4.3% |
| 17 | Velan Capital Investment Management LP | 549,985 | $8.0M | 4.9% | 1.1% | -5.7% |
| 18 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 540,126 | $7.9M | 0.0% | 1.1% | 0.0% |
| 19 | Woodline Partners LP | 531,254 | $7.7M | 0.0% | 1% | +64.0% |
| 20 | STATE STREET CORP | 510,814 | $7.4M | 0.0% | 1% | +1662.0% |
| 21 | Sofinnova Investments, Inc. | 500,039 | $7.3M | 0.4% | 1% | +379.0% |
| 22 | Jupiter Topco LLCNEW | 451,226 | $6.6M | 0.0% | 0.9% | new |
| 23 | MORGAN STANLEY | 432,220 | $6.3M | 0.0% | 0.8% | -27.5% |
| 24 | Qube Research & Technologies Ltd | 429,893 | $6.3M | 0.0% | 0.8% | +1419.9% |
| 25 | Siren, L.L.C. | 427,141 | $6.2M | 0.1% | 0.8% | 0.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.